Apollo Endosurgery to Present at June Investor Conferences tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.
AUSTIN, TX / ACCESSWWIRE / June 1, 2021 / Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures today announced
Avinger, Inc.: Avinger Announces Issuance and Allowance of Seven U.S. Patents
REDWOOD CITY, CA / ACCESSWIRE /
May 25, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced the issuance and allowance of seven U.S. patents to date in 2021.
These new U.S. patents include a wide range of claims relating to Avinger s proprietary optical coherence tomography (OCT) intravascular imaging system and its OCT-guided catheters for the treatment of vascular disease. With the addition of these patents and new filings made in 2021, Avinger s intellectual property portfolio now numbers 182 patents and pending applications, including 41 issued and allowed patents in the U.S. and 76 issued and allowed patents outside the U.S. The portfolio has broad applicability in the areas of atherectomy, CTO-crossing and intravascu
Avinger Announces Issuance and Allowance of Seven U.S. Patents
ACCESSWIRE
REDWOOD CITY, CA / ACCESSWIRE /
May 25, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced the issuance and allowance of seven U.S. patents to date in 2021.
These new U.S. patents include a wide range of claims relating to Avinger s proprietary optical coherence tomography (OCT) intravascular imaging system and its OCT-guided catheters for the treatment of vascular disease. With the addition of these patents and new filings made in 2021, Avinger s intellectual property portfolio now numbers 182 patents and pending applications, including 41 issued and allowed patents in the U.S. and 76 issued and allowed patents outside the U.S. The portfolio has broad applicability in the areas of atherectomy, CTO-crossing and intravascular
Avinger Announces Issuance and Allowance of Seven U S Patents pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.